RESULTS OF HOSPITAL USE OF RECOMBINANT NON-IMMUNOGENIC STAPHYLOKINASE IN PATIENTS WITH ST-ELEVATED MYOCARDIAL INFARCTION

Aim. To assess effectiveness and safety of the hospital use of recombinant non-immunogenic staphylokinase in patients with acute  ST-elevated myocardial infarction (STEMI).Material and methods. Recombinant non-immunogenic staphylokinase was administered during in-hospital stage of treatment of 93 pa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: V. B. Kostogryz
Formato: Artigo
Idioma:Inglês
Publicado em: Stolichnaya Izdatelskaya Kompaniya 2017-03-01
Colecção:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Assuntos:
acute st-elevated myocardial infarction
thrombolytic therapy
recombinant non-immunogenic staphylokinase
Acesso em linha:https://www.rpcardio.com/jour/article/view/1416
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados